Dr Jarosław Długołęcki

Dr Jarosław Długołęcki

Mr Jarosław Długołęcki

We are pleased to welcome a new member of the BRG medical expert team. Mr Jarosław Długołęcki, (M.D.) - doctor with extensive knowledge and 16-years’ experience in clinical studies at the international level. He cooperated with global pharmaceutical companies and conducted research in renowned centre's such as PAREXEL Intl Westend Hospital Berlin, Germany, Department of Clinical Pharmacology. In his professional path he leaded and manage as Global Study Leader, oncological study team ( phase III, lung cancer , 760 randomized patients) in 34 countries located in Europe, Asia, North and South America and Australia (Data Management, Medical Writing, Medical Monitoring, being responsible for the whole study processes. This study was inspected by EMEA, FDA, CFDA, PMDA successfully and obtained fast registration in EU, USA, Japan, China and other countries. He cooperates with the emergency department of Warsaw hospital, gaining extensive, practical, experience with severe forms of respiratory failure, requiring the use of various methods of supporting ventilation, circulatory failure and multi-organ failure.

He works part time as GP at one of facility doctor's center

Dr Długołęcki as the main investigator successfully performed 45 clinical trials in the following medical areas:

  • Rheumatoid Arthritis
  • Osteoarthritis
  • Lung cancer
  • Breast cancer
  • Skin cancer
  • Cervical cancer of the uterus
  • Hepatitis B
  • Nephrology
  • Hepatitis C
  • Multiple sclerosis
  • Asthma
  • COPD
  • Respiratory infections
  • Rheumatoid Arthritis
  • Osteoarthritis
  • Anemia
  • Rheumatoid Arthritis
  • Osteoarthritis
  • Heart failure

His substantial practice covers all phases of clinical trials. Currently, Dr. Długołęcki conducts specialized training for clinical research centres, CROs and pharmaceutical companies in the field of good practices, effective conducting of clinical trials as well GCP regulation, EU’s , FDA's Japan's and China's regulation as well as  Polish law regarding clinical study.

Dr Dlugolecki's motto is ,, Who is bored with clinical trials is bored with life”.

Go back

News

First phase study

We have just succesfully finished the second part of the first phase study with no Serious Adverse Events.

Read more …

Bioequivalence study

We have just finished clinical part of one of our ongoing bioequivalence Clinical Studies.

Read more …

Membership in SCRS

We have joined the Society for Clinical Research Sites (SCRS)!

 

Read more …

Open Recruitment to new study

We have started new study with testosterone for healthy Volunteers or Patients with testosterone deficiency.

Read more …

FIM study

We have just succesfully finished First in Man study with psychoactive substance.

Read more …

About Us | Services | Our Site | Partners | Smoking Risk Study | Contact Us

Early Phase Clinical Trials

2024 © Bio Research Group. All rights reserved.

 

scroll to top ▲